Mesothelioma Cancer Centers
The University of Chicago Medicine
Doctors Affiliated with this Treatment Facility
Located on the South Side of Chicago, University of Chicago Medicine is an academic medical center on the campus of the University of Chicago, a private research university. The medical center includes Bernard A. Mitchell Hospital, an adult patient facility; Comer Children’s Hospital; Chicago Lying-in Hospital, a maternity and women’s hospital; Duchossois Center for Advanced Medicine, an ambulatory-care facility; the University of Chicago Pritzker School of Medicine, one of the top medical schools in the United States; and affiliated doctors offices and hospitals across the Chicago metro area. University of Chicago Medicine is ranked nationally in twelve adult and nine pediatric specialties, according to U.S. News & World Report; the hospital’s cancer care ranked 14th nationally in 2012.
While the University of Chicago was founded in 1892, it took several decades for dreams of a medical campus to be realized. In 1916, the university’s trustees set aside more than $5 million for the construction and endowment of a hospital, but World War I waylaid the process, and it was not completed until 1927. But once the University of Chicago Hospitals was dedicated on Halloween 1927, it wasted no time before expanding. The Home for Destitute and Crippled Children was added in 1928, and the Country Home for Convalescent Children and Chicago Lying-in Hospital were integrated within about a decade.
A tremendous period of growth followed in the 1950s and 1960s with the addition of cancer research centers, research laboratories, a children’s hospital, and other facilities. More recently, University of Chicago has added the Brain Research Pavilion, the Aeromedical Network, the Duchossois Center for Advanced Medicine, and the newest addition, University of Chicago Comer Children’s Hospital.
Since the founding of University of Chicago Medicine, history has been there made time and time again. A University of Chicago doctor discovered a way to preserve blood and established the first civilian blood bank. Sleep research began at the university in the late 1920s, when a doctor established the world’s first sleep laboratory. In the early 1930s, the University of Chicago opened one of the first nurseries for premature infants. Cancer research has also grown immeasurably inside the University of Chicago’s walls; hormone treatments, chemotherapy and genetic links to cancers have all been discovered or advanced by groundbreaking research there.
Mesothelioma Treatment at University of Chicago Medicine
Cancer research got an added boost in 1973 with the founding of the University of Chicago Comprehensive Cancer Center (UCCCC). Through collaborative research involving 225 talented physicians and scientists, the center seeks to prevent and develop more effective treatments for various types of the disease. Today the UCCCC is one of just two National Cancer Institute-designated comprehensive cancer centers in the state of Illinois, and in 2011, it received the highest possible accreditation from the Commission on Cancer of the American College of Surgeons.
Mesothelioma is rare; with just 3,000 new cases diagnosed every year, it is a disease that requires specialized treatment from experienced professionals. Luckily for patients in Illinois, the University of Chicago Comprehensive Cancer Center has more than two decades of experience in the study and treatment of the disease. Treatment of mesothelioma at the UCCCC consists of a team approach, in which medical oncologists, surgeons, nurses, image specialists and others work together; in fact, they meet once a week to exchange knowledge and ideas at mesothelioma program meetings.
As a research hospital, clinical trials play an important role at University of Chicago Medicine. Many of the university’s clinical trials are conducted hand-in-hand with the National Cancer Institute, pharmaceutical companies and other collaborators, adding to the breadth of expertise brought to the table. Through these experimental trials, patients may gain access to new treatments, such as combinations of chemotherapy drugs. An easy-to-navigate website lists the studies currently ongoing at University of Chicago Medicine (see link below).
Author: Linda Molinari
Editor in Chief, Mesothelioma Cancer AllianceRead about Linda
Reviewer: Annette Charlevois
Patient Support CoordinatorRead about Annette
University of Chicago Medicine — History
University of Chicago Medicine — Firsts
U.S. News & World Report — University of Chicago Medicine
University of Chicago Cancer Care — Mesothelioma
University of Chicago Clinical Trials — Mesothelioma